Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy

Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy

Michael R Clausen,1 Matthew J Maurer,2 Sinna Pilgaard Ulrichsen,3 Thomas S Larsen,4 Bodil Himmelstrup,5 Dorthe Rønnov-Jessen,6 Brian K Link,7 Andrew L Feldman,8 Susan L Slager,2 Grzegorz S Nowakowski,9 Carrie A Thompson,9 Per Trøllund Pedersen,10 Jakob Madsen,11 Robert S Peders...

Full description

Bibliographic Details
Main Authors: Clausen MR, Maurer MJ, Ulrichsen SP, Larsen TS, Himmelstrup B, Rønnov-Jessen D, Link BK, Feldman AL, Slager SL, Nowakowski GS, Thompson CA, Pedersen PT, Madsen J, Pedersen RS, Gørløv JS, Cerhan JR, Nørgaard M, D'Amore F
Format: Article
Language:English
Published: Dove Medical Press 2019-11-01
Series:Clinical Epidemiology
Subjects:
diffuse large b-cell lymphoma
hemoglobin
prognosis
nccn-ipi
Online Access:https://www.dovepress.com/pretreatment-hemoglobin-adds-prognostic-information-to-the-nccn-ipi-in-peer-reviewed-article-CLEP

Internet

https://www.dovepress.com/pretreatment-hemoglobin-adds-prognostic-information-to-the-nccn-ipi-in-peer-reviewed-article-CLEP

Similar Items